MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 48 filers reported holding MARKER THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,000 | -58.3% | 14,799 | -60.8% | 0.00% | – |
| Q2 2022 | $12,000 | -87.1% | 37,800 | -81.9% | 0.00% | – |
| Q1 2022 | $93,000 | -87.6% | 209,336 | -73.5% | 0.00% | – |
| Q4 2021 | $752,000 | +16.0% | 790,204 | +106.3% | 0.00% | – |
| Q3 2021 | $648,000 | -34.4% | 383,081 | +8.2% | 0.00% | – |
| Q2 2021 | $988,000 | +23.7% | 354,015 | -0.8% | 0.00% | – |
| Q1 2021 | $799,000 | +715.3% | 356,828 | +430.6% | 0.00% | – |
| Q4 2020 | $98,000 | +113.0% | 67,250 | +118.3% | 0.00% | – |
| Q3 2020 | $46,000 | -48.9% | 30,800 | -29.4% | 0.00% | – |
| Q2 2020 | $90,000 | +26.8% | 43,641 | +16.9% | 0.00% | – |
| Q1 2020 | $71,000 | -74.9% | 37,339 | -62.1% | 0.00% | – |
| Q4 2019 | $283,000 | -76.7% | 98,408 | -58.6% | 0.00% | – |
| Q3 2019 | $1,213,000 | -58.6% | 237,431 | -35.9% | 0.00% | – |
| Q2 2019 | $2,932,000 | +373.7% | 370,189 | +294.4% | 0.00% | – |
| Q1 2019 | $619,000 | +255.7% | 93,860 | +200.2% | 0.00% | – |
| Q4 2018 | $174,000 | – | 31,261 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |